TipRanks
Cynata Therapeutics Limited (CYYNF)
OTHER OTC:CYYNF
US Market
CYYNF
Cynata Therapeutics Limited
RESEARCH TOOLSreports

Cynata Therapeutics Limited (CYYNF) Income Statement

5 Followers

Cynata Therapeutics Limited Income Statement

Last quarter (Q4 2026), Cynata Therapeutics Limited's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Cynata Therapeutics Limited's net income was AU$-6.43M. See Cynata Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 1.71MAU$ 1.89MAU$ 2.32MAU$ 1.65MAU$ 7.77M
Gross Profit
AU$ -260.31KAU$ 1.89MAU$ 2.32MAU$ 1.37MAU$ 7.49M
Operating Expenses
AU$ 9.42MAU$ 10.01MAU$ 11.12MAU$ 16.26MAU$ 12.06M
Depreciation and Amortization
AU$ 260.31KAU$ 282.96KAU$ 279.96KAU$ 279.96KAU$ 279.96K
EBITDA
AU$ -7.55MAU$ -9.33MAU$ -9.95MAU$ -15.65MAU$ -6.00M
Operating Income
AU$ -9.68MAU$ -8.12MAU$ -8.81MAU$ -16.54MAU$ -6.90M
Other Income/Expenses
AU$ -1.28MAU$ -1.27MAU$ -3.25MAU$ 610.71KAU$ 622.45K
Pretax Income
AU$ -10.96MAU$ -9.39MAU$ -12.06MAU$ -15.93MAU$ -6.28M
Net Income
AU$ -9.09MAU$ -9.39MAU$ -9.74MAU$ -14.28MAU$ -5.45M
Per Share Metrics
Basic EPS
AU$ -0.04AU$ -0.05AU$ -0.05AU$ -0.10AU$ -0.04
Diluted EPS
AU$ -0.04AU$ -0.05AU$ -0.05AU$ -0.10AU$ -0.04
Weighted Average Shares Outstanding
 236.70M 204.95M 179.63M 145.09M 143.28M
Weighted Average Shares Outstanding (Diluted)
 236.70M 204.95M 179.63M 145.09M 143.28M
Currency in AUD

Cynata Therapeutics Limited Earnings and Revenue History